File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Erxian decoction stimulates estrogen secretion via steroidogenic signaling transduction pathway in vivo

TitleErxian decoction stimulates estrogen secretion via steroidogenic signaling transduction pathway in vivo
Authors
Issue Date2008
PublisherMary Ann Liebert, Inc.
Citation
The 3rd International Congress on Complementary Medicine Research, Sydney, Australia, 29-31 March 2008. In Journal of Alternative and Complementary Medicine, 2008, v. 14 n. S1, p. S-83 Abstract no. 296 How to Cite?
AbstractPeri-menopause is the period during which estrogen secreted by the ovaries gradually declines and patients suffer from much higher incidences of body and mental changes, such as hot flashes. Perimenopause is normally treated by hormone replacement therapy. However, such treatment may increase incidence of different side effects, e.g. breast cancer and stroke. Therefore, scientists are seeking alternative therapeutic approaches, such as Chinese Medicine. Erxian decoction (EXD), a Chinese medicinal formulation has clinically been practiced more than 50 years in relieving perimenopausal syndrome via stimulation of estrogen secretion without side effects. However, its action mechanisms are still unknown. Therefore, a quality control study of EXD using HPLC has been performed and its action mechanisms in estrogen secretion in a peri-menopausal animal model (aged SD-Rat) have been explored. Our results show that 1) seventeen major constituents in EXD have been detected using HPLC and their relevant components of jatrorrhizine, palmatine and berberine were eluted at a retention time of 49.221 min, 50.602 min and 51.265 min respectively, homogeneity 99.99% and 2) EXD could promote a gene expression of steroidogenic enzyme in peri-menopausal rat which directly induces estrogen synthesis. Results obtained from this study provided the new information to develop the effective therapy and open new alternatives for the treatment of peri-menopausal syndrome.
Persistent Identifierhttp://hdl.handle.net/10722/114432
ISSN
2015 Impact Factor: 1.395
2015 SCImago Journal Rankings: 0.475

 

DC FieldValueLanguage
dc.contributor.authorSze, CWen_HK
dc.contributor.authorLau, ASYen_HK
dc.contributor.authorZhang, Yen_HK
dc.contributor.authorTong, Yen_HK
dc.date.accessioned2010-09-26T05:00:11Z-
dc.date.available2010-09-26T05:00:11Z-
dc.date.issued2008en_HK
dc.identifier.citationThe 3rd International Congress on Complementary Medicine Research, Sydney, Australia, 29-31 March 2008. In Journal of Alternative and Complementary Medicine, 2008, v. 14 n. S1, p. S-83 Abstract no. 296-
dc.identifier.issn1075-5535-
dc.identifier.urihttp://hdl.handle.net/10722/114432-
dc.description.abstractPeri-menopause is the period during which estrogen secreted by the ovaries gradually declines and patients suffer from much higher incidences of body and mental changes, such as hot flashes. Perimenopause is normally treated by hormone replacement therapy. However, such treatment may increase incidence of different side effects, e.g. breast cancer and stroke. Therefore, scientists are seeking alternative therapeutic approaches, such as Chinese Medicine. Erxian decoction (EXD), a Chinese medicinal formulation has clinically been practiced more than 50 years in relieving perimenopausal syndrome via stimulation of estrogen secretion without side effects. However, its action mechanisms are still unknown. Therefore, a quality control study of EXD using HPLC has been performed and its action mechanisms in estrogen secretion in a peri-menopausal animal model (aged SD-Rat) have been explored. Our results show that 1) seventeen major constituents in EXD have been detected using HPLC and their relevant components of jatrorrhizine, palmatine and berberine were eluted at a retention time of 49.221 min, 50.602 min and 51.265 min respectively, homogeneity 99.99% and 2) EXD could promote a gene expression of steroidogenic enzyme in peri-menopausal rat which directly induces estrogen synthesis. Results obtained from this study provided the new information to develop the effective therapy and open new alternatives for the treatment of peri-menopausal syndrome.-
dc.languageengen_HK
dc.publisherMary Ann Liebert, Inc.-
dc.relation.ispartofJournal of Alternative and Complementary Medicineen_HK
dc.titleErxian decoction stimulates estrogen secretion via steroidogenic signaling transduction pathway in vivoen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailSze, CW: stephens@hku.hken_HK
dc.identifier.emailZhang, Y: ybzhang30@hotmail.comen_HK
dc.identifier.emailLau, ASY: asylau@hku.hken_HK
dc.identifier.emailTong, Y: tongyao@hkucc.hku.hken_HK
dc.identifier.authorityLau, ASY=rp00474en_HK
dc.identifier.authorityTong, Y=rp00509en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1089/acm.2008.ISCMR.1-
dc.identifier.pmid18399784-
dc.identifier.hkuros141894en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats